A biotech company, Altay Therapeutics Inc is structured around finding and discovering small molecule therapies for chronic inflammatory conditions. With the firm's assembled team of scientists having expertise in transcription factor biology and clinical drug development, Altay Therapeutics employs an integrated approach to drug development to include biochemical assays, next-generation computational biology and chemoproteomics. Management objective and mission are to develop more specific and safer therapies to extend the lives of patients through their proprietary platform and drug development approach designed to develop novel small molecule drugs targeting disease-causing transcription factors to treat chronic illnesses and cancers.
